Skip to main content
. Author manuscript; available in PMC: 2016 Jun 24.
Published in final edited form as: Lancet. 2015 Oct 1;386(10012):2489–2498. doi: 10.1016/S0140-6736(15)00347-5

Table 7.

Commonly reported adverse events (Safety patient population)

AE description Tight control N (%) Standard care N (%) Total N (%)
Abdominal / GI upset, n (%) 35 (5·6) 13 (5·3) 48 (5·5)
  Number of patients, n (%) 31 (30·7%) 12 (11·4%) 43 (20·9%)
Fatigue (Asthenia, lethargy, malaise), n (%) 33 (5·3) 8 (3·3) 41 (4·7)
  Number of patients, n (%) 22 (21·8%) 8 (7·6%) 30 (14·6%)
Headache / Migraine, n (%) 27 (4·4) 11 (4·5) 38 (4.4)
  Number of patients, n (%) 20 (19·8%) 7 (6·7%) 27 (13·1%)
Infection (Common cold), n (%) 46 (7·4) 14 (5·7) 60 (6·9)
  Number of patients, n (%) 34 (33·7%) 13 (12·4%) 47 (22·8%)
Liver enzyme abnormalities, n (%) 37 (6·0) 39 (15·9) 76 (8·8)
  Number of patients, n (%) 23 (22·8%) 28 (26·7%) 51 (24·8%)
Musculoskeletal pain, n (%) 28 (4·5) 8 (3·3) 36 (4·2)
  Number of patients, n (%) 22 (21·8%) 6 (5·7%) 28 (13·6%)
Nausea, n (%) 54 (8·7) 38 (15·4) 92 (10·6)
  Number of patients, n (%) 36 (35·6%) 27 (25·7%) 63 (30·6%)

Number and % of events is out of 620 events in the TC arm and 246 events in the StdC arm.

Number and % of patients is out of 101 patients in the TC arm and 105 patients in the StdC arm.